Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01229137 · ClinicalTrials.gov registry record
Physiological Response to Exercise: Sensor Evaluation at Specified Exertions
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 71
- Enrollment target
NCT01229137: Completed study, sponsored by Boston Scientific Corporation.
NCT01229137 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01229137 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
Assessment of sensor parameter in patients with heart failure.
Interventions
- DEVICE SRD-1 conversion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-08 |
What the finished NCT01229137 record still lists
NCT01229137 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 71 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SRD-1 conversion is the first listed.
NCT01229137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01229137 about?
NCT01229137 is a clinical study titled "Physiological Response to Exercise: Sensor Evaluation at Specified Exertions". Assessment of sensor parameter in patients with heart failure.
What is the current status of trial NCT01229137?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2011-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01229137?
The interventions under investigation include: SRD-1 conversion (DEVICE).
Who is sponsoring clinical trial NCT01229137?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia